首日被納入港股通,阿里巴巴收升,成交額放大至169億港元
納入港股通首日,阿里巴巴(9988.HK)盤中一度升5.3%至82.45港元,最終收升4.21%報81.6港元,全天成交169億港元,明顯放大。摩根士丹利稱,阿里巴巴今日起獲納入港股通,時間符合預期,估計未來1年將會吸引170億至370億美元南向資金淨流入,持股比例介乎8%至17%,並指近期阿里股價有不少短線催化劑,包括3年整改完成、淘天平台將引入微訊支付,以及即將推出軟件服務,估計有助下半年客户管理收入,以及商品交易額增速差距收窄。該行維持阿里巴巴“與大市同步”評級及美股90美元的目標價。另外,傑富瑞給予其港股目標價112港元,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.